Dynamic Optical Coherence Tomography: A Non-Invasive Imaging Tool for the Distinction of Nevi and Melanomas

Cancers (Basel). 2022 Dec 20;15(1):20. doi: 10.3390/cancers15010020.

Abstract

Along with the rising melanoma incidence in recent decades and bad prognoses resulting from late diagnoses, distinguishing between benign and malignant melanocytic lesions has become essential. Unclear cases may require the aid of non-invasive imaging to reduce unnecessary biopsies. This multicentric, case-control study evaluated the potential of dynamic optical coherence tomography (D-OCT) to identify distinguishing microvascular features in nevi. A total of 167 nevi, including dysplastic ones, on 130 participants of all ages and sexes were examined by D-OCT and dermoscopy with a histological reference. Three blinded analyzers evaluated the lesions. Then, we compared the features to those in 159 melanomas of a prior D-OCT study and determined if a differential diagnosis was possible. We identified specific microvascular features in nevi and a differential diagnosis of melanomas and nevi was achieved with excellent predictive values. We conclude that D-OCT overcomes OCT´s inability to distinguish melanocytic lesions based on its focus on microvascularization. To determine if an addition to the gold standard of a clinical-dermoscopic examination improves the diagnosis of unclear lesions, further studies, including a larger sample of dysplastic nevi and artificial intelligence, should be conducted.

Keywords: D-OCT; dynamic optical coherence tomography; dysplastic nevus; melanoma; nevus; non-invasive diagnostics in dermatology; skin cancer screening; skin imaging; skin microvascularization; unclear melanocytic lesions.

Grants and funding

This study was run within the framework of the ADVANCE (Automatic Detection of Vascular Networks for Cancer Evaluation) project (Number 621015) and received funding from the European Union´s ICT Policy Support Program as part of the Competitiveness and Innovation Framework Program.